Skip to search formSkip to main contentSkip to account menu

100 ML eptifibatide 0.75 MG/ML Injection

Known as: EPTIFIBATIDE 0.75MG/ML INJ, EPTIFIBATIDE 0.75 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION, EPTIFIBATIDE 0.75MG/ML INJ [VA Product] 
National Institutes of Health

Related topics

Related topics

18 relations

Narrower (1)

100 ML eptifibatide 0.75 MG/ML Injection [Integrilin]
Angina, UnstableCerebral InfarctionCoronary heart diseaseDrug Allergy

Broader (1)

Anticoagulants

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Assessment of Eptifibatide Clearance by Hemodialysis Using an in vitro System
Background/Aims: Eptifibatide is a parenteral glycoprotein IIb-IIIa inhibitor that prevents platelet aggregation. Although… 
2004
2004
Reversibility versus Persistence of GPIIb/IIIa Blocker-Induced Conformational Change of GPIIb/IIIa (αIIbβ3, CD41/CD61)
Clinically used GPIIb/IIIa blockers are ligand mimetics, and thereby their binding can induce conformational changes of the… 
2004
2004
Alveolar hemorrhage associated with periprocedural eptifibatide administration.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)